Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.

MLA

Bersanelli, Melissa, et al. “Systematic Vitamin D Supplementation Is Associated with Improved Outcomes and Reduced Thyroid Adverse Events in Patients with Cancer Treated with Immune Checkpoint Inhibitors: Results from the Prospective PROVIDENCE Study.” Cancer Immunology, Immunotherapy : CII, vol. 72, no. 11, Nov. 2023, pp. 3707–16. EBSCOhost, https://doi.org/10.1007/s00262-023-03522-3.

APA

Bersanelli, M., Cortellini, A., Leonetti, A., Parisi, A., Tiseo, M., Bordi, P., Michiara, M., Bui, S., Cosenza, A., Ferri, L., Giudice, G. C., Testi, I., Rapacchi, E., Camisa, R., Vincenzi, B., Caruso, G., Rauti, A. N., Arturi, F., Tucci, M., … Buti, S. (2023). Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study. Cancer Immunology, Immunotherapy : CII, 72(11), 3707–3716. https://doi.org/10.1007/s00262-023-03522-3

Chicago

Bersanelli, Melissa, Alessio Cortellini, Alessandro Leonetti, Alessandro Parisi, Marcello Tiseo, Paola Bordi, Maria Michiara, et al. 2023. “Systematic Vitamin D Supplementation Is Associated with Improved Outcomes and Reduced Thyroid Adverse Events in Patients with Cancer Treated with Immune Checkpoint Inhibitors: Results from the Prospective PROVIDENCE Study.” Cancer Immunology, Immunotherapy : CII 72 (11): 3707–16. doi:10.1007/s00262-023-03522-3.